Data on long-term risks and benefits of weight loss drugs are derived from studies on medically needy populations.

“the first and the second are true and what they really tell you is therefore the cost benefit analysis has to be viewed through the lens of that patient population in other words when you ask the question about risk and benefit you have to at least acknowledge that the long-term risk long-term benefit are studied in that population and as such this is what the data are these are the risks these are the benefits make your judgment”